New ABO intron 1 variant alleles

Fennell, K.; Keller, M.A.; Villa, M.A.; Paccapelo, C.; Kucerakova, M.; Rosochova, J.; Clemente DosSantos, C.; Brackney, L.; Lee, C.J.; Metcalf, R.; Crovetti, G.; Barbieri, M.; Travali, S.; Barrotta, G.; Giuca, G.; Guerra, L.E.; Ochoa-Garay, G.

doi:10.21307/immunohematology-2021-029

Abstract

Unusual and discrepant ABO phenotypes are often due to genetic variants that lead to altered levels or activity of ABO transferases and consequently to altered expression of ABO antigens. This report describes eight genetic alterations found in 15 cases with reduced or undetectable expression of ABO antigens. Forward and reverse ABO grouping was performed by standard gel or tube methods. Adsorption-heat elution and saliva testing for H and A substances followed the AABB technical manual procedures. Genomic DNA extracted from whole blood was PCR-amplified to cover the entire ABO coding sequence, splice junctions, proximal promoter, and intron 1 enhancer. Amplification products were sequenced by next-generation or Sanger dideoxy methods, either directly or after cloning into a bacterial plasmid vector. Eight unreported alleles were found in the 15 cases analyzed. Alleles ABO*A(28+1C) and ABO*A(29–5G) harbor variants that alter the consensus sequence at the intron 1 donor and acceptor splice sites, respectively. The other alleles harbor variants that alter the consensus sequence at transcription factor–binding sites in the intron 1 enhancer: specifically, ABO*A(28+5792T), ABO*A(28+5859A), and ABO*A(28+5860G) at GATA-1 sites; ABO*B(28+5877T) and ABO*B(28+5878G) at a RUNX1 site; and ABO*A(28+5843A) at or near a C/EBP site. Molecular and serologic characterization of ABO alleles can help in their future identification and in the resolution of discrepancies.

References

Cai X, Jin S, Liu X, et al. Molecular genetic analysis of ABO blood group variations reveals 29 novel ABO subgroup alleles. Transfusion 2013;53:2910–6.
Search in Google Scholar Back to article
Vege S, Lomas-Francis C, Aeschlimann J, et al. Three novel ABO alleles and associated serologic phenotypes give insights for bioinformatics and NGS. Transfusion 2017;57(Suppl 3):44A(C52-A03H).
Search in Google Scholar Back to article
Sano R, Nakajima T, Takahashi Y, et al. Expression of ABO blood-group genes is dependent upon an erythroid cell– specific regulatory element that is deleted in persons with the Bm phenotype. Blood 2012;119:5301–10.
Search in Google Scholar Back to article
Nakajima T, Sano R, Takahashi Y, et al. Mutation of the GATA site in the erythroid cell–specific regulatory element of the ABO gene in a Bm subgroup individual. Transfusion 2013;53: 2917–27.
Search in Google Scholar Back to article
Takahashi Y, Isa K, Sano R, et al. Deletion of the RUNX1 binding site in the erythroid cell-specific regulatory element of the ABO gene in two individuals with the Am phenotype. Vox Sang 2014;106:167–75.
Search in Google Scholar Back to article
Takahashi Y, Isa K, Sano R, et al. Presence of nucleotide substitutions in transcriptional regulatory elements such as the erythroid cell-specific enhancer-like element and the ABO promoter in individuals with phenotypes A3 and B3, respectively. Vox Sang 2014;107:171–80.
Search in Google Scholar Back to article
Sano R, Kuboya E, Nakajima T, et al. A 3.0-kb deletion including an erythroid cell-specific regulatory element in intron 1 of the ABO blood group gene in an individual with the Bm phenotype. Vox Sang 2015;108:310–3.
Search in Google Scholar Back to article
Oda A, Isa K, Ogasawara K, et al. A novel mutation of the GATA site in the erythroid cell specific regulatory element of the ABO gene in a blood donor with the AmB phenotype. Vox Sang 2015;108:425–7.
Search in Google Scholar Back to article
Tao C, Xiao J, Hu Y, et al. A novel B allele with c.28+5885C>T substitution in the erythroid cell–specific regulatory element identified in an individual with phenotype B3. Transfusion 2017;57:1318–9.
Search in Google Scholar Back to article
Ogasawara K, Miyazaki T, Ito S, et al. The B allele with a 5.8 kb deletion in intron 1 of the ABO gene is the major allele in Japanese individuals with Bm and A1Bm phenotypes. Vox Sang 2018;113:393–6.
Search in Google Scholar Back to article
Ying Y, Hong X, Xu X, et al. A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population. Vox Sang 2018;113:594–600.
Search in Google Scholar Back to article
Wu PC, Lin Y-H, Tsai LF, et al. ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepancies. Transfusion 2018;58:2232–42.
Search in Google Scholar Back to article
Ouellette K, Stephanie K, Sweeney J. Adsorption-elution in a weak B subgroup due to a polymorphism in the enhancer region of intron 1 of the B allele. Transfusion 2018;58(Suppl S2):194A(IGT86).
Search in Google Scholar Back to article
Hult AK, Hellberg A, Hosseini-Maaf B, et al. Disrupted RUNX1 motifs in the ABO gene explain samples with A3 and B3 phenotypes. Vox Sang 2020;115(Suppl 1):15(3A-S04-03).
Search in Google Scholar Back to article
Stef M, Fennell K, Apraiz I, et al. RH genotyping by nonspecific quantitative next-generation sequencing. Transfusion 2020; 60:2691–701.
Search in Google Scholar Back to article
Thuresson B, Hellberg A, Olsson ML. Disruption of a binding site for the erythroid transcription factor GATA-1 in intron 1 of the ABO gene in Am and Bm subgroup samples. Vox Sang 2013;105(Suppl 1):44(3C-S22-04).
Search in Google Scholar Back to article
JASPAR. A database of transcription factor binding profiles. Available from http://jaspar.genereg.net/. Accessed 20 January 2021.
Search in Google Scholar Back to article

New ABO intron 1 variant alleles

Abstract

Paradigm

My account